Drug information for DOXERCALCIFEROL

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 0.5MCG Prescription AB  DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol ROXANE 91433
2011-11-07 Letter
CAPSULE; ORAL 1MCG Tentative Approval   DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol ROXANE   "
CAPSULE; ORAL 2.5MCG Tentative Approval   DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol ROXANE   "
INJECTABLE; INJECTION 2MCG/ML Tentative Approval   DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol COBREK PHARMA 90040
2011-03-18 Letter
INJECTABLE; INJECTION 2MCG/ML Tentative Approval   DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol MYLAN PHARMA 91101
INJECTABLE; INJECTION 2MCG/ML Tentative Approval   DOXERCALCIFEROL 1 alpha-hydroxyergocalciferol SANDOZ 91333

Drug Adverse Effects information for DOXERCALCIFEROL

Role code Indications Reaction # Reports
C NUCLEAR MAGNETIC RESONANCE IMAGING GAIT DISTURBANCE 3
C NUCLEAR MAGNETIC RESONANCE IMAGING LOCALISED OEDEMA 3
C NUCLEAR MAGNETIC RESONANCE IMAGING MUSCULOSKELETAL STIFFNESS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING NEPHROGENIC SYSTEMIC FIBROSIS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN 3
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN IN EXTREMITY 3
C NUCLEAR MAGNETIC RESONANCE IMAGING RASH MACULAR 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN FIBROSIS 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERPIGMENTATION 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERTROPHY 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN INDURATION 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN PLAQUE 3
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN TIGHTNESS 3
Ads by Google